Dr. Kishore Kumar Kota

Dr kishore kota

Dr. Kishore Kumar Kota

Medical and Hemato-Oncologist

MD, DM (Medical Oncology)

Experience : 5+ Years

Expertise : Medical Oncology

Experience

Dr. Kishore Kumar Kota is a Medical and Hemato – Oncologist at Mahatma Gandhi Cancer Hospital & Research Institute, Visakhapatnam. He has over 6 yrs of experience in offering Specialized Oncology Care. 

  • He worked as an Ad hoc Assistant professor, in Medical Oncology, TMH, Mumbai.
  • He worked as an Ad hoc Assistant professor, of Medical Oncology, at HBCH & RC, Muzaffarpur.

Expertise

Area(s) of Interest

  • Lung, Breast, Ovarian , Urological Malignancies
  • Young and adolescent Malignancies : Germcell Tumors, Lymphomas, Gestational Trophoblastic Diseases
  • Bone Marrow Transplant

Treatment(s)/ Procedure(s) Performed

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Palliative and Supportive Care
  • Prevention and Screening of Cancer
  • Solid Malignancies – Breast, Gynaecology, Gastroenterology, Thoracic, Urology, Head & Neck, Bone & Soft Tissue, CNS.
  • Hematolymphoid Malignancies – ALL, AML, Lymphoma, CLL, CML, MPN, MDS

Treatment(s)/ Procedure(s) Offered

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Palliative and Supportive Care
  • Prevention and Screening of Cancer
  • Breast, Gynaecology, Gastroenterology, Thoracic, Urology, Head and Neck, and CNS Malignancies
  • Young & Adolescent Malignancies
  • Hematolymphoid Malignancies
  • Bone Marrow Transplantation.

Doctor’s ScoreCard

The number of cases of  Medical & Hemato-Oncology Performed by Dr. Kishore Kumar Kota in the last 5+ years

Total: 2000

Education & Training

Name of Institute(s)

  • DM (Medical Oncology), Tata Memorial Hospital, Mumbai.
  • MD from Nizam Institute of Medical Sciences, Hyderabad.
  • MBBS from Rangaraya Medical College, Kakinada.

Training

Trained at Bone Marrow Transplantation Unit, TMH Mumbai.

Professional Highlights

Publications

  • Diclofenac versus tramadol for mucositis-related pain in Head and Neck Cancer Patients undergoing concurrent chemoradiation —a phase 3 study
  • A randomized open-label phase III study evaluating olanzapine 2.5mg Vs 10mg plus standard triple antiemetic therapy for prevention of chemotherapy-induced nausea & vomiting in patients receiving highly emetogenic cisplatin-based chemotherapy in solid tumors: A phase III study  (Ongoing study)
  • Evaluation of metronomic therapy in desmoid fibromatosis: Real-world data from a tertiary care center from a large developing country  (Ongoing study).
  • Covid-19 vaccine uptake and vaccine hesitancy in Indian patients with cancer: A questionnaire-based survey.

Professional Achievements & Membership

  • Member of Andhra Pradesh Medical Council – Registration Number: 71731
  • Registered Member of Maharashtra State Medical Council.
  • Member of ISMPO 
  • Member of ASCO 

Breakthrough Case(s) & Testimonial(s)

Breakthrough Case(s)

 1.Cutaneous T cell Lymphoma : Middle Aged Female Achieved Complete Response after Chemotherapy.

2. Achieved Cure in Major Number of Treated Germcell Tumors, Gestational Trophoblastic Tumors , Lymphomas.